Your browser doesn't support javascript.
loading
Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.
Pyra, Maria; Brown, Elizabeth R; Haberer, Jessica E; Heffron, Renee; Celum, Connie; Bukusi, Elizabeth A; Asiimwe, Stephen; Katabira, Elly; Mugo, Nelly R; Baeten, Jared M.
Afiliação
  • Pyra M; Department of Epidemiology, University of Washington, Seattle, USA.
  • Brown ER; Department of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, WA, 98104, USA.
  • Haberer JE; Department of Biostatistics, University of Washington, Seattle, USA.
  • Heffron R; Vaccine and Infection Diseases and Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Celum C; Massachusetts General Hospital Global Health, Boston, USA.
  • Bukusi EA; Department of Medicine, Harvard Medical School, Boston, USA.
  • Asiimwe S; Department of Epidemiology, University of Washington, Seattle, USA.
  • Katabira E; Department of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, WA, 98104, USA.
  • Mugo NR; Department of Epidemiology, University of Washington, Seattle, USA.
  • Baeten JM; Department of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, WA, 98104, USA.
AIDS Behav ; 22(11): 3718-3725, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30006791
Understanding how women use PrEP is important for developing successful implementation programs. We hypothesized there are distinct patterns of adherence, related to HIV risk and other factors. We identified patterns of PrEP adherence and HIV risk behavior over the first 6 months of PrEP use, using data from 233 HIV-uninfected women in high-risk serodiscordant couples in a demonstration project in Kenya & Uganda. We modeled PrEP adherence, assessed by daily electronic monitoring, and HIV risk behavior using group-based trajectory models. We tested baseline covariates and risk behavior group as predictors of adherence patterns. There were four distinct adherence patterns: high steady adherence (55% of population), moderate steady (29%), late declining (8%), and early declining (9%). No baseline characteristics significantly differed between adherence patterns. Adherence patterns differed in average weekly doses (6.7 vs 5.4 vs 4.1 vs 1.5, respectively). Two risk behavior groups were identified: steady HIV risk (78% of population) and declining (22%). Compared to women with declining HIV risk behavior, women with steady risk behavior were more likely to have high steady adherence (61% vs 35%) and less likely to have early (6% vs 17%) or late (4% vs 19%) declining adherence. Women's use of PrEP was associated with concurrent HIV risk behavior; higher risk was associated with higher, sustained adherence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Adesão à Medicação / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Adesão à Medicação / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article